Primary Health CareNCT07552311
Generative AI Plan for Care Lab Study
A study testing Fitbit Plan for Care Lab and Baseline Model in people with Primary Health Care, run by Fitbit LLC at 1 site in United States.
Trial summary
This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disclose, and a summary… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Primary Health Care
- What is being tested?
- Fitbit Plan for Care Lab and Baseline Model
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40,000 participants
- Where
- 1 siteUnited States
- Study dates
- 21 Nov 2025to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age of majority: are of legal adult age (18 or older in most US states; 19 or older in Nebraska \& Alabama, or 21 or older in Mississippi)
- Resides in the United States
- Fitbit mobile user using their Google accounts on an Android smartphone
- Able to read, write and willing to consent in English
Who cannot join
- Enrollment using a corporate google.com account
- Have a condition or circumstance that the investigator determines as inappropriate for participation.
- Have a chief complaint or symptoms that are potentially related to mental health disorders, sexually transmitted diseases or infections, or pregnancy.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Google LLC
Mountain View, California, 94043
Matthew Thompson, MD, 6506090742, mthomp@google.com
About this study
Official title: Generative AI Pre-visit Lab Study
This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disclose, and a summary of information to bring to a health care visit if planned.
- Conditions
- Primary Health Care
- Being tested
- Fitbit Plan for Care Lab, Baseline Model
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Fitbit Plan for Care LabOther
A user informational tool using generative AI models
Baseline ModelOther
Plan for Care baseline model
| Study group | Role | What they receive |
|---|---|---|
| Arm A - Baseline | Active comparator | Baseline Urgency and Baseline Pre-visit Model Receives: Other: Baseline Model |
| Arm B - Urgency and Pre-visit Model 1 | Experimental | Urgency and Pre-visit Model 1 Receives: Other: Fitbit Plan for Care Lab |
| Arm C - Urgency and Pre-visit Model 2 | Experimental | Urgency and Pre-visit Model 2 Receives: Other: Fitbit Plan for Care Lab |
What is being measured
The primary outcome is the main question the study is designed to answer.
Participant Self-Reported assessment
Determine participants' self-reported assessment of the pre-visit experience, such as satisfaction on a likert scale
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Apr 2026
- Study start21 Nov 2025
- Primary completion30 Nov 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Primary Health CareStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 40,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fitbit LLC
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Google LLC.
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07552311
- Sponsor's protocol ID
- GH-BMX-01
- Status last verified
- Apr 2026
- First submitted
- 13 Apr 2026
- Last updated
- 27 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 27 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Generative AI Pre-visit Lab Study
- ClinicalTrials.gov ID
- NCT07552311
- Acronym / sponsor ID
- GH-BMX-01
- Conditions
- Primary Health Care
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40,000 participants (estimated)
- Lead sponsor
- Fitbit LLCIndustry (pharma, biotech, devices)
- Collaborators
- Google LLC.
- Study start
- 21 Nov 2025 (actual)
- Primary completion
- 30 Nov 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 27 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disclose, and a summary of information to bring to a health care visit if planned.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Arm A - Baseline | Active comparator | Other: Baseline ModelBaseline Urgency and Baseline Pre-visit Model |
| Arm B - Urgency and Pre-visit Model 1 | Experimental | Other: Fitbit Plan for Care LabUrgency and Pre-visit Model 1 |
| Arm C - Urgency and Pre-visit Model 2 | Experimental | Other: Fitbit Plan for Care LabUrgency and Pre-visit Model 2 |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Age of majority: are of legal adult age (18 or older in most US states; 19 or older in Nebraska \& Alabama, or 21 or older in Mississippi)
- Resides in the United States
- Fitbit mobile user using their Google accounts on an Android smartphone
- Able to read, write and willing to consent in English
Key exclusion criteria (3 listed)
- Enrollment using a corporate google.com account
- Have a condition or circumstance that the investigator determines as inappropriate for participation.
- Have a chief complaint or symptoms that are potentially related to mental health disorders, sexually transmitted diseases or infections, or pregnancy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Fitbit Plan for Care LabA user informational tool using generative AI models | Other | Arm B - Urgency and Pre-visit Model 1, Arm C - Urgency and Pre-visit Model 2 |
| Baseline ModelPlan for Care baseline model | Other | Arm A - Baseline |
Primary outcome
Participant Self-Reported assessment
Time frame: Day 1
Determine participants' self-reported assessment of the pre-visit experience, such as satisfaction on a likert scale
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Apr 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Primary Health Care
Enrolling by invitation
TimelyCare - A Proactive Primary Care Model: Delivering the Right Care at the Right Time for Individuals at Risk of High Care Consumption
Multimorbidity, Integrated Care
Recruiting
Testing the Impact of the MOHR Follow-up Support
Primary Care Patients, Primary Care Center
Not yet recruiting
HERE: Health Empowerment and Resources After Pregnancy
Cardiovascular Health
Not yet recruiting
Study Comparing Osteoarthritis Programs
Osteoarthritis
Not yet recruitingObservational study
Clinical Governance of Home Care and 30-Day Stability
Home Care Services, Quality of Health Care
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Fitbit Plan for Care Lab and Baseline Model in people with Primary Health Care, run by Fitbit LLC at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Bhavna Daryani, BDS (2018859852, bhavnad@google.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Participant Self-Reported assessment (time frame: Day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2026.